L. Ebony Boulware, MD, MPH; Spyridon Marinopoulos, MD, MBA; Karran A. Phillips, MD, MSc; Constance W. Hwang, MD; Kenric Maynor, MD; Dan Merenstein, MD; Renee F. Wilson, MSc; George J. Barnes, BA; Eric B. Bass, MD, MPH; Neil R. Powe, MD, MPH, MBA; Gail L. Daumit, MD, MHS
Boulware LE, Marinopoulos S, Phillips KA, Hwang CW, Maynor K, Merenstein D, et al. Systematic Review: The Value of the Periodic Health Evaluation. Ann Intern Med. 2007;146:289-300. doi: 10.7326/0003-4819-146-4-200702200-00008
Download citation file:
Published: Ann Intern Med. 2007;146(4):289-300.
The periodic health evaluation (PHE) has been a fundamental part of medical practice for decades despite a lack of consensus on its value.
To synthesize the evidence on benefits and harms of the PHE.
Electronic searches of such databases as MEDLINE and the Cochrane Library, review of reference lists, and hand- searching of journals through September 2006.
Studies (English-language only) assessing the delivery of preventive services, clinical outcomes, and costs among patients receiving the PHE versus those receiving usual care.
Study design and settings, descriptions of the PHE, and clinical outcomes associated with the PHE.
The best available evidence assessing benefits or harms of the PHE consisted of 21 studies published from 1973 to 2004. The PHE had a consistently beneficial association with patient receipt of gynecologic examinations and Papanicolaou smears, cholesterol screening, and fecal occult blood testing. The PHE also had a beneficial effect on patient â€œworryâ€ in 1 randomized, controlled trial but had mixed effects on other clinical outcomes and costs.
Descriptions of the PHE and outcomes were heterogeneous. Some trials were performed before U.S. Preventive Services Task Force guidelines were disseminated, limiting their applicability to modern practice.
Evidence suggests that the PHE improves delivery of some recommended preventive services and may lessen patient worry. Although additional research is needed to clarify the long-term benefits, harms, and costs of receiving the PHE, evidence of benefits in this study justifies implementation of the PHE in clinical practice.
Pap = Papanicolaou.
*Total may exceed 1284; several reasons for exclusion at the abstract level were allowed. †A total of 50 articles were included in the data abstraction. These 50 articles represented 33 studies that reported multiple outcomes and multiple follow-ups. ‡Total may exceed 769; several reasons for exclusion at the article inclusion/exclusion review level were allowed. CINAHL = Cumulative Index of Nursing and Alliance Health Literature; PHE = periodic health evaluation.
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only